New Cancer Gene Therapy Study Findings Have Been Published by a Researcher at University of Nicosia (Gene Therapy with Chitosan Nanoparticles: Modern Formulation Strategies for Enhancing Cancer Cell Transfection).

A recent study conducted by researchers at the University of Nicosia in Cyprus explores the use of gene therapy for cancer treatment. The study focuses on the use of chitosan nanoparticles as carriers for delivering nucleic acids to cancer cells. Chitosan, a biopolymer, has advantages such as stable nanocomplex formation and cellular uptake promotion, but it also faces challenges like poor solubility and non-specificity for cancer cells. The researchers propose strategies to enhance the functionality of chitosan nanoparticles, including improving stability, targeting specificity, cellular uptake efficiency, and endosomal escape. This study provides valuable insights for advancing chitosan-based gene delivery systems in cancer therapy. [Extracted from the article]

Copyright of Cancer Gene Therapy Week is the property of NewsRx and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)